- In September 2023, Insight Medbotics The FDA granted 510(k) clearance for the IGAR system, a robotic guidance and placement system compatible with MRI, specifically engineered for breast biopsy procedures. This advancement highlights Insight Medbotics' commitment to developing cutting-edge technologies that enhance precision and diagnostic outcomes in challenging biopsy scenarios, ensuring greater accuracy and patient safety
- In June 2023, Medtronic plc, Medtronic introduced the Bioprobe Precision biopsy needle system, specifically designed for lung and liver biopsies. This innovative system underscores Medtronic's dedication to delivering advanced, reliable tools that improve tissue sampling accuracy and procedural efficiency in critical internal organ biopsies, reinforcing its position in the rapidly evolving global needle biopsy market
- In May 2023, Argon Medical Devices launched the SuperCore Advantage, a new semi-automatic biopsy instrument for the U.S. market. This device is engineered to provide a superior volume of tissue samples for soft tissue biopsies, which may increase the likelihood of accurate diagnosis. This development highlights Argon Medical's commitment to enhancing diagnostic confidence and patient outcomes through improved sample quality
- In April 2023, BD acquired Velano Vascular, a strategic move aimed at enhancing its biopsy needle portfolio. This acquisition underscores BD's dedication to delivering innovative, reliable access solutions that improve patient experience and expand its offerings in the global needle biopsy market
- In May 2024, Cook Medical announced the launch of the next-generation EchoTip AcuCore Endoscopic Ultrasound (EUS) Biopsy Needle. This needle is designed to improve precision for biopsying lesions within the gastrointestinal tract, showcasing Cook Medical's commitment to advancing minimally invasive diagnostic capabilities
- In November 2024, Mammotome introduced the Mammotome AutoCore Single Insertion Core Biopsy System, the first automated spring-loaded core needle biopsy system to be launched in the marketplace. This new product launch signifies Mammotome's continued dedication to furthering breast biopsy technology and optimizing patient care results through increased efficiency
